The University of Sherbrooke is a large public French-language university in Quebec, Canada with campuses located in Sherbrooke and Longueuil, a suburb of Montreal approximately 130 km west of Sherbrooke.

During the past decade, Université de Sherbrooke conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 3 clinical trials were completed, i.e. on average, 8.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Université de Sherbrooke" #1 sponsor was "Université de Sherbrooke" with 14 trials, followed by "University of British Columbia" with 4 trials sponsored, "Centre de recherche du Centre hospitalier universitaire de Sherbrooke" with 3 trials sponsored, "Ottawa Heart Institute Research Corporation" with 3 trials sponsored and "Sunnybrook Health Sciences Centre" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Université de Sherbrooke" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 13 trials as a collaborator, "Université de Montréal" with 4 trials as a collaborator, "Université de Sherbrooke" with 4 trials as a collaborator, "CHU de Quebec-Universite Laval" with 3 trials as a collaborator and "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 3 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Université de Sherbrooke" are "Covid19" (3 trials), "Critically Ill" (3 trials), "Heart Failure" (3 trials), "Parkinson Disease" (3 trials) and "Bacteremia" (2 trials). Many other conditions were trialed in "Université de Sherbrooke" in a lesser frequency.

Most popular intervention types in "Université de Sherbrooke" are "Drug" (21 trials), "Other" (18 trials), "Device" (7 trials), "Diagnostic Test" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Advanced Imaging" (2 trials), "Once daily screening" (2 trials), "Standard Imaging" (2 trials) and "14 days of adequate antibiotic treatment durations" (1 trials). Other intervention names were less common.

The vast majority of trials in "Université de Sherbrooke" are 52 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Université de Sherbrooke". undefined are not yet recruiting, 16 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Université de Sherbrooke, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Université de Sherbrooke, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 24 trials that are defined as “Not Applicable".

Université de Sherbrooke has several departments that took part in Clinical trials: "Rearsh Centre on Aging" - 6 trials, "Research Centre on Aging" - 5 trials, "Centre Hospitalier Universitaire de Sherbrooke, departement de cardiologie" - 3 trials, "Centre de recherche sur le vieillissement CIUSSS de l'Estrie-CHUS" - 2 trials